# US 2024/0002834 A1 · Adenine base editor lacking cytosine editing activity and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002834 A1
- Document ID: US20240002834A1
- Status: Published application
- Kind: A1
- Application number: 18/039,632
- Filed: 2021-12-01
- Published: 2024-01-04
- Earliest claimed: 2020-12-01
- Assignees: Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University); Korea University Research and Business Foundation
- Applicants: Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University); Korea University Research and Business Foundation
- Inventors: Sangsu BAE; You Kyeong JEONG; Seokhoon LEE; Jae-Sung WOO
- Web page: https://patentgrep.com/patent/US20240002834A1

## CPC

- C12N 15/102: {Mutagenizing nucleic acids}
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 9/78: acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- C12Y 305/04005: Cytidine deaminase (3.5.4.5)
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12Y 305/04004: Adenosine deaminase (3.5.4.4)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present invention relates to an adenine base editor from which cytosine editing activity is removed, a method of editing an adenine base, and method of editing an adenine base. In the present invention, it was confirmed that four mutations (V106W, D108Q, F148A and F149A) in adenosine deaminase increase the specificity for adenine editing by reducing cytosine base editing efficiency, and ABE variants were manufactured by introducing respective mutations into a variety of more improved adenine base editors than ABEmax, and tested, confirming that the mutations significantly decrease a cytosine editing effect. Therefore, the adenine base editor according to the present invention is able to more accurately edit adenine, and the method of editing an adenine base can be effectively used in the field of gene therapy that has to accurately edit only adenine in all living organisms including humans, plants and bacteria or novel crop development.

## Claims

### Claim 1

A cytosine editing activity-removed adenine base editor in which adenosine deaminase variant and a CRISPR-associated protein 9 (Cas9) protein are fused,
wherein the variant has one or more mutations selected from the group consisting of V106W, D108Q, F148A and F149A.

### Claim 2 (depends on 1)

The adenine base editor of claim 1, wherein the mutation is introduced into any one selected from the group consisting of ABEmax, ABEmax-m, ABE8e, ABE8e-V106W and ABE8.17-m.

### Claim 3 (depends on 1)

The adenine base editor of claim 1, which has improved specificity for adenine base editing.

### Claim 4 (depends on 1)

The adenine base editor of claim 1, which has reduced RNA editing activity.

### Claim 5 (depends on 1)

An adenine (A) base editing composition, comprising:
the adenine base editor of claim 1; and
guide RNA (single guide RNA; sgRNA).

### Claim 6 (depends on 5)

The composition of claim 5, which substitutes adenine (A) with any one base selected from the group consisting of guanine (G), cytosine (C) and thymine (T).

### Claim 7 (depends on 5)

A method of editing an adenine (A) base, comprising:
bringing the adenine base editing composition of claim 5 into contact with a target sequence in vitro.

### Claim 8 (depends on 5)

A kit for adenine (A) base editing, comprising the adenine base editing composition of claim 5.
